Ya Jiao Mu Pi

Ya Jiao Mu Pi (duck foot tree bark) is the dried root bark of Schefflera heptaphylla (L.) Frodin, an evergreen tree or shrub in the family Araliaceae. In the traditional southern Chinese folk medicine system, Ya Jiao Mu Pi is considered bitter and pungent in flavor with a cool nature. It enters the Liver, Spleen, and Kidney meridians, and is traditionally used for patterns involving Wind-Damp Bi syndrome, blood stasis, and traumatic injuries.

Botanical description: Schefflera heptaphylla is an evergreen tree or large shrub that can reach 3–15 m in height. The leaves are palmately compound, typically with 6–9 leaflets (occasionally up to 11), arranged in a radiating pattern resembling an open duck foot — a characteristic that gives the plant its common name. The leaflets are oblong-elliptic to obovate, 7–17 cm long and 3–6 cm wide, with entire margins, leathery texture, and a glossy dark green upper surface. The flowers are small, greenish-white to pale yellow, borne in terminal umbellate panicles. The fruit is a small globose drupe, 4–5 mm in diameter, turning purple-black when ripe. The root bark, the medicinal part, is rough, brownish-grey on the outer surface with longitudinal cracks and lenticels, and pale yellowish-brown on the inner surface.

Habitat and distribution: S. heptaphylla is native to southern China, Taiwan, and parts of Southeast Asia. In China, the primary regions where it is found and traditionally used include Guangdong, Guangxi, Hainan, Fujian, and Yunnan provinces. The plant thrives in tropical and subtropical climates, growing in lowland forests, secondary woodlands, stream banks, and disturbed areas from sea level to about 800 m elevation. It is also widely cultivated as an ornamental tree and houseplant. The root bark is harvested from mature trees, typically in autumn, cleaned, cut into strips or slices, and dried in the sun for medicinal use.

Quality markers: Unlike mainstream pharmacopoeial herbs, Ya Jiao Mu Pi does not have standardized quality markers defined in the Chinese Pharmacopoeia. In folk practice, the highest-quality material is described as being thick, rough-textured, brownish-grey on the outside, and pale yellowish-brown on the inner surface, with a characteristic mild odor and slightly bitter taste. The absence of pharmacopoeial standards means that quality control and chemical standardization of commercial Ya Jiao Mu Pi preparations are not well established.

In the traditional Chinese medicine theoretical framework, Ya Jiao Mu Pi is understood in terms of its effects on specific patterns of disharmony (zheng). Because Ya Jiao Mu Pi enters the Liver, Spleen, and Kidney meridians and has a bitter, pungent, and cool quality, it is traditionally indicated for a range of patterns involving Wind-Dampness, blood stasis, and traumatic injuries.

Dispelling Wind-Dampness and stopping pain: Ya Jiao Mu Pi is traditionally used in southern Chinese folk medicine for Wind-Damp Bi syndrome, a TCM pattern characterized by rheumatic pain, joint stiffness, and muscle soreness that migrates or is fixed in specific locations. By dispelling Wind-Dampness from the channels and collaterals, Ya Jiao Mu Pi is believed to alleviate pain and restore normal joint function. It is traditionally combined with other Wind-Damp dispelling herbs such as Qiang Huo and Fang Feng in folk formulas targeting rheumatic conditions.

Promoting blood circulation and removing blood stasis: Ya Jiao Mu Pi is traditionally used to invigorate blood circulation and resolve blood stasis, which in TCM theory is believed to be the underlying cause of many types of fixed, sharp pain. It is indicated for traumatic injuries such as contusions, sprains, and fractures, where it is believed to promote the resorption of hematomas, reduce swelling, and accelerate tissue repair. The herb can be used both internally as a decoction and externally as a wash or poultice for these purposes.

Reducing swelling and promoting tissue repair: In southern Chinese folk medicine, Ya Jiao Mu Pi is also traditionally used for reducing swelling associated with traumatic injuries and inflammatory conditions. Its ability to "reduce swelling and promote tissue healing" (xiao zhong sheng ji) is a commonly cited traditional indication. For external application, the dried root bark is ground into powder and mixed with water or wine to form a paste, which is applied directly to the affected area.

Folk medicine and ethnobotanical context: Ya Jiao Mu Pi is a regional folk herb rather than a classical TCM herb with documented entries in the major classical materia medica. Its traditional use is primarily documented through ethnobotanical studies and local folk medicine records from southern China. An ethnobotanical study by Lu et al. (2022, PMID: 35729593) documented that Schefflera heptaphylla is one of the most frequently cited medicinal plants among the Yao people in Gongcheng County, Guangxi, with a high relative frequency of citation (RFC) value, indicating its cultural importance and widespread traditional use in this region. The Yao people use it primarily for treating traumatic injuries, rheumatic conditions, and digestive system ailments.

This description reflects traditional TCM theory and is not a modern medical diagnosis or treatment claim.

Ya Jiao Mu Pi contains a range of bioactive compounds that have been the subject of phytochemical investigation. The following overview summarizes the major chemical constituents identified in the root bark and stem bark of Schefflera heptaphylla and what is currently known about them from published research.

Triterpenoid saponins (heptursosides, heptoleosides, heptdamoside): The triterpenoid saponins are the most extensively studied class of compounds from Schefflera heptaphylla. Wu et al. (2013, PMID: 23925903) isolated nine new triterpenoid saponins from the stem barks, including four ursane-type saponins (heptursosides A-D), four oleanane-type saponins (heptoleosides A-D), and one dammarane-type saponin (heptdamoside A). Several of these compounds (heptursoside B, heptoleoside C, heptoleoside D, and asiaticoside D) demonstrated anti-inflammatory activity in pre-clinical in-vitro models by inhibiting lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophages. In a follow-up study (2014, PMID: 24144797), five additional new ursane-type triterpenoid saponins were isolated, with compounds 2 and 5 showing weak anti-inflammatory activities.

Ursane-type triterpenoids: Wu et al. (2011, PMID: 21534042) isolated a new ursane-type triterpenoid, along with 15 known compounds, from the barks of S. heptaphylla. The structure of the new compound was determined through extensive spectroscopic analysis including IR, HR-ESI-MS, 1D and 2D NMR, and confirmed by single-crystal X-ray diffraction. Compounds 2-6 were reported from the Schefflera genus for the first time in this study.

Betulinic acid and related triterpenes: Liu et al. (2019, PMID: 31842361) isolated three main lupanine triterpenes from the active fractions of S. heptaphylla ethanol extract, including betulinic acid 3-O-sulfate and 3alpha-hydroxy-lup-20(29)-ene-23,28-dioic acid. Betulinic acid derivatives are known for their diverse biological activities, including anti-inflammatory and pro-coagulant effects. Compound B (betulinic acid 3-O-sulfate) was identified as the main pro-coagulant constituent in the in-vitro and in-vivo assays.

Essential oil constituents: Li et al. (2009, PMID: 18814213) analyzed the essential oil from the leaves of S. heptaphylla by GC-MS and identified 27 volatile compounds, 17 of which were monoterpenes or sesquiterpenes. The main volatile constituent was beta-pinene, comprising approximately 22% of the total volatile components. The essential oil showed significant antiproliferative activity against three human cancer cell lines (MCF-7, A375, and HepG2) with IC50 values of 7.3, 7.5, and 6.9 microg/mL, respectively.

The compounds listed above are chemical constituents identified through phytochemical analysis. Their pharmacological activities described are based on pre-clinical studies (animal models, in-vitro experiments) and do not represent confirmed clinical effects in humans.

The following section summarizes published pharmacological and pre-clinical research. Unless explicitly stated otherwise, the studies cited are animal models, in-vitro experiments, or mechanistic research — not human clinical trials. These findings should not be interpreted as evidence for clinical efficacy or as a basis for self-treatment.

Pro-coagulant and hemostatic effects: Liu et al. (2019, PMID: 31842361) conducted the most comprehensive pharmacological study on S. heptaphylla to date, investigating its coagulant effects and mechanism. The ethanol extract, ethyl acetate phase, and n-butanol phase all demonstrated significant pro-coagulant activity in both in-vitro coagulation assays (PT, APTT, TT, FIB) and in-vivo rat models. The study further identified betulinic acid 3-O-sulfate (compound B) as the main pro-coagulant constituent. The mechanism was associated with regulation of vascular endothelium active substances (TXB2, 6-keto-PGF1alpha, eNOS, ET-1) and hemorheology parameters. The tail bleeding method confirmed the traumatic bleeding and hemostasis activities of the extracts. These results provide scientific support for the traditional use of S. heptaphylla for traumatic bleeding.

Anti-inflammatory activity: Multiple studies have reported anti-inflammatory effects of triterpenoid saponins from S. heptaphylla. Wu et al. (2013, PMID: 23925903) demonstrated that several isolated saponins (heptursoside B, heptoleoside C, heptoleoside D, and asiaticoside D) inhibited LPS-induced nitric oxide production in RAW264.7 macrophages at non-cytotoxic concentrations. Wu et al. (2014, PMID: 24144797) reported that two additional new ursane-type triterpenoid saponins showed weak anti-inflammatory activities in the same assay. While these findings are scientifically interesting, they represent preliminary in-vitro data, and their clinical significance for human inflammatory conditions has not been established.

Antiproliferative activity of essential oil: Li et al. (2009, PMID: 18814213) investigated the chemical composition and antiproliferative activity of the essential oil from S. heptaphylla leaves. The oil showed significant activity against MCF-7 (breast), A375 (melanoma), and HepG2 (liver) cancer cell lines. The study also confirmed that beta-pinene, the major constituent, possessed antiproliferative activity, though with higher IC50 values (147.1-264.7 micromolar) compared to the crude essential oil. This suggests that the antiproliferative effect may result from synergistic interactions among multiple constituents.

Ethnobotanical documentation: Lu et al. (2022, PMID: 35729593) conducted an ethnobotanical survey of the Yao people in Gongcheng County, Guangxi, and documented that Schefflera heptaphylla is one of the most frequently cited medicinal plants (RFC = 0.056), used primarily for treating traumatic injuries, rheumatic disease, and digestive system ailments. This study provides important documentation of the cultural and traditional medicinal value of this plant among the Yao ethnic group.

What the research does NOT show: Despite the promising pre-clinical signals, the research on Ya Jiao Mu Pi and its active compounds does NOT demonstrate conclusive clinical efficacy for any specific disease in humans. There are no published clinical trials involving human subjects. The translation from in-vitro and animal models to human clinical relevance is uncertain. This page does not endorse Ya Jiao Mu Pi as a treatment for any condition.

Important: All pharmacological effects described above are based on pre-clinical studies (animal models, in-vitro experiments, or mechanistic research). They do not constitute evidence of clinical efficacy in humans. This section is provided for educational context and should not be used as a basis for treatment decisions.

General safety profile: Ya Jiao Mu Pi is a regional folk herb with very limited safety data. Unlike mainstream pharmacopoeial herbs, it has not been systematically evaluated for toxicity, adverse effects, or drug interactions in controlled clinical studies. The information below reflects what is currently known from published literature, traditional folk experience, and general safety considerations for herbal products.

Cool nature and appropriate use: In traditional TCM theory, Ya Jiao Mu Pi is bitter and cool in nature. Individuals with cold-type pain patterns — where pain is alleviated by warmth and aggravated by cold — should generally avoid or use it with caution. Its cool nature also means it may not be appropriate for individuals with Spleen deficiency presenting as loose stools, poor digestion, abdominal distension, and cold extremities. The herb should only be used under professional guidance with appropriate warming herbs when concurrent conditions exist.

Blood-activating effects: Because Ya Jiao Mu Pi is traditionally believed to promote blood circulation and remove blood stasis, caution is warranted in individuals with bleeding disorders, those taking anticoagulant or antiplatelet medications, and those scheduled for surgery. Pre-clinical data suggest pro-coagulant effects (Liu et al., 2019), which theoretically could have implications for individuals with thrombotic conditions. However, human data are insufficient to draw definitive conclusions.

Pregnancy and lactation: Ya Jiao Mu Pi does not have a specific traditional contraindication during pregnancy, but its blood-activating property suggests that caution is warranted. In TCM theory, herbs that strongly activate blood circulation are generally avoided during pregnancy due to the theoretical risk of disturbing fetal stability. There are no modern clinical data on the safety of Schefflera heptaphylla constituents during pregnancy or lactation. Do not use Ya Jiao Mu Pi during pregnancy without direct supervision from a qualified healthcare professional.

Drug interactions: There are no published clinical studies on drug interactions involving Ya Jiao Mu Pi. Pre-clinical data on the triterpenoid saponins and other constituents are insufficient to draw conclusions about potential drug interaction mechanisms. Theoretically, the pro-coagulant effects reported in pre-clinical models could potentially interact with anticoagulant (e.g., warfarin) or antiplatelet (e.g., aspirin, clopidogrel) medications. However, clinical data confirming this interaction in humans are lacking. Consult a qualified healthcare professional before combining Ya Jiao Mu Pi with any prescription medications.

Reported side effects: There are no systematically reported adverse effects associated with Ya Jiao Mu Pi in the published scientific literature. The lack of reported adverse effects does not necessarily mean the herb is free of risk, as it may simply reflect the limited clinical research and usage. Any suspected adverse effects should be reported to a healthcare professional.

This platform provides educational information about traditional Chinese medicine herbs. It does not recommend, endorse, or prescribe the use of Ya Jiao Mu Pi or any other herbal product for the treatment of any medical condition. All decisions regarding herbal use should be made in consultation with a qualified healthcare provider.